May 19, 2016 – MONTREAL, QUEBEC – Relevium Technologies Inc. (TSX.V – “RLV”) (Frankfurt: “6BX”) (the “Company” or “Relevium”) is pleased to announce it has executed a letter of intent to acquire a controlling interest and progressively 100% of a Montreal-based B2B distribution and D2C E-retail company that specializes on high quality exclusive performance products and technologies for North America.
The acquisition target is a growing distribution and D2C company with an existing revenue base of over $500,000.00 CAD through a narrow and focused number of products, which are expected to grow organically at a rate of 50% per year. The acquisition target is currently in the process of negotiating the expansion of its product offering and is anticipating introducing several new SKUs, all of which are expected to translate into significant increase in market reach and revenues. The proposed transaction, the details of which will be disclosed upon execution of a definite agreement, is expected to become Relevium’s main distribution and E-retail capability for new technologies and exclusive products for North America by leveraging its experienced team and established relationships with specialty stores and major retail chains across the US and Canada.
In addition to the current performance products sold by the acquisition target, Relevium also plans to utilize and leverage the new partnership to develop a new platform for launching, distributing and retailing connected sports performance products, specialized nutritional supplements, innovative pain management devices and recovery products, all in line with the Company’s overall strategy. The addition of the new products and technologies as well as the addition of E-retail capabilities are estimated to materially increase revenues and as well as branding strength of the Company.
Leena Lakdawala, CEO of Relevium Technologies stated: “As part of our growth strategy, this partnership is expected to provide Relevium access to an established and growing network of performance and wellness retailers both in Canada and the US. The proposed target counts with an experienced team who truly understands the role of relationship and trust-based selling, both of which represent the basis for a successful distribution, retail and D2C strategy”
The transaction is expected to close within the next 30 days and is subject to customary due diligence, market compliance and financing.
About Relevium Technologies Inc.
Relevium is a TSXV listed company focused on growth through the acquisition of businesses, products and/or technologies within the scope of the expanding health and wellness sector, specifically under three important verticals: Pain Relief, Recovery and Performance. Relevium currently holds patented intellectual property for application of static magnetic fields on direct-to-consumer devices, which aid in decreasing pain, improving recovery time and enhancing overall physical performance.
On Behalf of the Board of Directors
RELEVIUM TECHNOLOGIES INC.
CEO and Director
For additional information, please contact:
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the business and operations of the Company. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals; and the ability of the Company to execute and achieve its business objectives. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. There can be no assurance that the conditions to the transactions contemplated by the potential letter of intents will be satisfied or that those transactions will be completed. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.